-
Eight New Companies Have Spun Out of the University of Washington in the Past Six Months
UW on track to double the number of spin-outs this fiscal year over the past five year average SEATTLE — The University of Washington Center for Commercialization (C4C) announced today that eight start-ups have spun out from the research work and innovations of faculty and students in the past six months. The university-generated companies are founded around a broad range of technologies from medical devices… View More
-
Medical Software Company PatientStream Attracts $500,000 Venture Investment From the W Fund
Developed at UW Harborview Medical Center, PatientStream’s Technology Modernizes How Surgery Teams Communicate PatientStream, a new company that has developed an innovative electronic patient tracking system for hospitals, has garnered $500,000 in funding from the W Fund and its partners. The service is currently being used in more than 50 departments across the University of Washington Medical Center, Harborview Medical Center, Seattle Cancer Care Alliance… View More
-
C4C’s Training Xchange Featured in UW Medicine Consult
C4C’s Training Xchange, a program that bridges the gap between UW researchers and health care practitioners, is featured in the Winter edition of UW Medicine Consult. Consult is a a quarterly UW Medicine publication that goes out to practitioners in the northwest (Washington, Wyoming, Alaska, Montana, Idaho and Oregon). The program, founded in 2009 by UW’s Dr. Paul Ciechanowski and Allison Waddell, converts research results… View More
-
UW Researchers Demonstrate Mild Brain Cooling After Head Injury Prevents Epileptic Seizures in Lab Study
[Excerpted from UW Today] According to an animal study reported this month in the Annals of Neurology, mild cooling of the brain after a head injury prevents the later development of epileptic seizures. “These findings demonstrate for the first time that prevention of epileptic seizures after traumatic brain brain injury is possible, and that epilepsy prophylaxis in patients could be achieved more easily than previously… View More
-
UW Spin-out PhysioSonics Gets FDA Approval for Monitoring Brain Blood Flow
PhysioSonics, a UW spin-out company founded in 2000 by Robert Frederickson, Michel Kliot, Pierre Mourad, and Jeffrey Jarvik, has won approval from the FDA to start selling its Presto 1000 Flow Monitor system in the U.S., according to CEO Brad Harlow. The technology automates the way technicians and physicians monitor blood flow in the brain. Instead of having a technician manually hold an ultrasound transducer… View More
-
UW Spin-out Cardiac Insight’s Heart Monitor and Software featured in Seattle Business Magazine
In 2010, UW cardiologist David Linker founded the start-up Cardiac Insight with CEO Brad Harlow to produce a device, called the Stealth Ambulatory Monitor, which uses an algorithm that quickly and accurately detects an irregular heartbeat. It’s the size of a watchband and weighs a quarter of an ounce. Cardiac Insight is licensing the patent for the monitor from the University of Washington. “We’ve made… View More
-
C4C AnnouncesFall 2012 Commercialization Gap Fund Awards
Nine Research Teams Receive $420,000 to Develop Fledgling Technologies The UW Center for Commercialization (C4C) today announced the award of $420,000 in Commercialization Gap Funds (CGF) to nine UW research teams currently working on promising technologies. The CGF program is a partnership between the C4C and the Washington Research Foundation to provide up to $1.25 million per year to support projects that have a high… View More
-
UW’s Promising Therapeutic for Celiac Disease featured in “Chemical and Engineering News”
Celiac disease is one of several diseases involving intolerance to dietary gluten protein that causes serious health problems. UW researcher Ingrid Swanson Pultz and Justin Siegel of the University of California at Davis are developing a promising therapeutic for celiac disease and gluten intolerance that was invented using advanced computational enzyme design. The result, KumaMax, breaks down gluten under the harsh conditions of the human… View More
-
UW Spin-out SNUPI launches with $1.5 million in funding
SNUPI Technologies, a new UW spin-out company that takes advantage of the wiring already in homes to create a wireless sensor network, launched today with $1.5 million in funding from Madrona Venture Group, Radar Partners and the founders. The technology, also called SNUPI (Sensor Network Utilizing Powerline Infrastructure), was developed at the University of Washington and Georgia Institute of Technology by Professors Shwetak Patel and… View More
-
UW Spinout Kona Medical Raises $10 Million More in Series C Funding
Kona Medical Inc. has raised $10 million in new Series C equity and debt financing.That brings its Series C total to $40 million, including $30 million raised in May. The Series C round included two large-cap strategic investors who joined with prior investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western Technology Investments, BioStar Ventures, and individuals in the financing. Silicon Valley Bank provided the debt… View More
Follow Us On Twitter
Join Our Mailing List